Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways
- PMID: 24905636
- DOI: 10.1016/j.intimp.2014.05.026
Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways
Abstract
Metastasis is one of the most important factors related to prostate cancer therapeutic efficacy. In previous studies, shikonin, an active naphthoquinone isolated from the Chinese medicine Zi Cao, has various anticancer activities both in vivo and in vitro. However, the mechanisms underlying shikonin's anticancer activity are not fully elucidated on prostate cancer cells. In the present study, we aimed to investigate the potential effects of shikonin on prostate cancer cells and the underlying mechanisms by which shikonin exerted its actions. With cell proliferation, flow cytometric cell cycle, migration and invasion assays, we found that shikonin potently suppressed PC-3 and DU145 cell growth by cell cycle arrest at the G2 phase and metastasis in a dose-dependent manner. Mechanically, we presented that shikonin could suppress the metastasis of PC-3 and DU145 cells via inhibiting the matrix metalloproteinase-2 (MMP-2) and MMP-9 expression and activation. In addition, shikonin significantly decreased the phosphorylation of AKT and mTOR in a dose-dependent manner while it induced extracellular signal-regulated kinase (ERK), p38 mitogen activated protein kinase (MAPK) and c-Jun N terminal kinase (JNK) phosphorylation. Further investigation of the underlying mechanism revealed that shikonin also induced the production of reactive oxygen species (ROS) that was reversed by the ROS scavenger dithiothreitol (DTT). Additionally, DTT reversed the shikonin induced activation of ERK1/2, thereby maintaining MMP-2 and MMP-9 expression and restoring cell metastasis. Together, shikonin inhibits aggressive prostate cancer cell migration and invasion by reducing MMP-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways and presents a potential novel alternative agent for the treatment of human prostate cancer.
Keywords: Human prostate cancer; Invasion; Matrix metalloproteinase; Migration; Shikonin.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.Toxicology. 2013 Jun 7;308:104-12. doi: 10.1016/j.tox.2013.03.015. Epub 2013 Apr 4. Toxicology. 2013. PMID: 23562787
-
Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.Apoptosis. 2013 Jul;18(7):870-81. doi: 10.1007/s10495-013-0835-5. Apoptosis. 2013. PMID: 23546866
-
Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells.Int J Oncol. 2012 Oct;41(4):1513-9. doi: 10.3892/ijo.2012.1560. Epub 2012 Jul 18. Int J Oncol. 2012. PMID: 22825655
-
The Fascinating Effects of Baicalein on Cancer: A Review.Int J Mol Sci. 2016 Oct 9;17(10):1681. doi: 10.3390/ijms17101681. Int J Mol Sci. 2016. PMID: 27735841 Free PMC article. Review.
-
Promising Anticancer Activities of Alismatis rhizome and Its Triterpenes via p38 and PI3K/Akt/mTOR Signaling Pathways.Nutrients. 2021 Jul 18;13(7):2455. doi: 10.3390/nu13072455. Nutrients. 2021. PMID: 34371964 Free PMC article. Review.
Cited by
-
Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.Cell Oncol (Dordr). 2017 Jun;40(3):247-261. doi: 10.1007/s13402-017-0320-1. Epub 2017 Apr 11. Cell Oncol (Dordr). 2017. PMID: 28401486
-
RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment.Sci Rep. 2018 Feb 8;8(1):2672. doi: 10.1038/s41598-018-21065-x. Sci Rep. 2018. PMID: 29422643 Free PMC article.
-
Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.Sci Rep. 2017 Jun 6;7(1):2863. doi: 10.1038/s41598-017-02671-7. Sci Rep. 2017. PMID: 28588262 Free PMC article.
-
RETRACTED: Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.Int J Mol Sci. 2015 Oct 9;16(10):23823-48. doi: 10.3390/ijms161023823. Int J Mol Sci. 2015. Retraction in: Int J Mol Sci. 2025 Jun 20;26(13):5922. doi: 10.3390/ijms26135922. PMID: 26473829 Free PMC article. Retracted.
-
Enzalutamide-induced signatures revealed by epigenetic plasticity using single-cell multi-omics sequencing in prostate cancer.Mol Ther Nucleic Acids. 2023 Feb 18;31:648-661. doi: 10.1016/j.omtn.2023.02.022. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2023. PMID: 36910711 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous